Celltrion Holdings

Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...

South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

South Korea’s Hyundai Motor Group kept its title as the world's third-largest automaker by sales volume for the second straight year in 2023, ...

Lotte Duty Free held a grand opening ceremony for its Changi Airport store in Singapore, marking the official start of its 19 stores.Lotte Duty Free...

South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, picked information tech, electric and electronic s...

South Korea’s second-largest automaker Kia Corp. plans to establish a sales subsidiary in Thailand as part of its electric vehicle push in the...

South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, saw the amount of listed local shares it owns rise...

South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

South Korea’s entertainment powerhouse CJ ENM Co. announced on Thursday that it will hold its annual K-pop festival KCON in Hong Kong for the ...

South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

Viva Republica Inc., the operator of South Korea’s fintech platform Toss, has revived plans to go public after pushing back its stock market d...

South Korean Kakao Pay Corp.'s takeover deal of US-based Siebert Financial Corp. has failed amid the growing legal risks surrounding top executives ...

Cho Yang-rai, honorary chairman of Hankook & Company Co., has vowed to fight MBK Partners Ltd.’s bid to take over the holding company of S...

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...

South Korea's JW Holdings corporation announced on Tuesday that it started to export the multi-nutritional liquid Winuf Central 736·1085ml to...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

Corporate governance and management transparency have long been the big issues influencing the so-called Korea Discount, alongside labor strife and ...

Samsung Electronics Co., the world’s largest memory chipmaker, has divested a 0.3% stake in Dutch chip equipment manufacturer ASML Holdings N....

South Korea's P&O Chemical, a joint venture of POSCO Future M Co. and OCI Holdings Co. completed the pitch plant in Tancheon Industrial Complex,...

South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...